Xiaoxia Wen Selected Research

paclitaxel poliglumex (XYOTAX)

6/2011	Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.
3/2011	Peptide-based imaging agents targeting phosphatidylserine for the detection of apoptosis.
7/2007	Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids.
1/2004	Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoxia Wen Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 10/2003
7	Adenocarcinoma 04/2020 - 04/2013
5	Breast Neoplasms (Breast Cancer) 03/2015 - 11/2003
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 01/2018
3	Fibrosis (Cirrhosis) 11/2021 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2020 - 01/2018
3	Carcinogenesis 08/2014 - 09/2005
3	Carcinoma (Carcinomatosis) 04/2014 - 04/2013
2	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2005
2	Liver Neoplasms (Liver Cancer) 08/2021 - 01/2020
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 09/2005
2	Melanoma (Melanoma, Malignant) 01/2017 - 03/2011
2	Squamous Cell Carcinoma of Head and Neck 08/2007 - 09/2005
1	Papillary Thyroid Cancer 12/2021
1	Arthritis (Polyarthritis) 01/2019
1	Airway Remodeling 01/2018
1	Triple Negative Breast Neoplasms 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 11/2016
1	Anaplastic Thyroid Carcinoma 07/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2014
1	Colorectal Neoplasms (Colorectal Cancer) 09/2013

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 01/2022 - 04/2013
5	Epidermal Growth Factor (EGF)IBA 11/2021 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2003
5	Contrast MediaIBA 07/2007 - 11/2003
4	GoldIBA 01/2020 - 11/2016
4	Cetuximab (Erbitux)FDA Link 05/2018 - 11/2003
4	paclitaxel poliglumex (XYOTAX)IBA 06/2011 - 01/2004
3	CollagenIBA 11/2021 - 01/2018
3	TOR Serine-Threonine KinasesIBA 08/2014 - 04/2013
3	Peptides (Polypeptides)IBA 01/2012 - 04/2009
3	ErbB Receptors (EGF Receptor)IBA 06/2011 - 11/2003
3	Annexin A5IBA 06/2011 - 10/2003
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2021 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 11/2021 - 01/2018
2	LigandsIBA 04/2020 - 05/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 11/2016
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	cupric sulfide (CuS)IBA 08/2019 - 07/2015
2	Biological ProductsIBA 01/2018 - 09/2005
2	Sirolimus (Rapamycin)FDA Link 09/2013 - 04/2013
2	Pentetic Acid (DTPA)FDA LinkGeneric 08/2011 - 07/2007
1	3-hydroxyphenyltrimethylammoniumIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 11/2021
1	Circular RNAIBA 08/2021
1	calcipotriene (calcipotriol)FDA LinkGeneric 05/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2021
1	2- (4- isothiocyanatobenzyl)- 1,4,7- triazacyclononane- 1,4,7- triacetic acidIBA 04/2020
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2020
1	2- (4- isothiocyanatobenzyl)- 1,4,7,10- tetraazacyclododecane tetraacetic acidIBA 04/2020
1	AntibodiesIBA 04/2020
1	Chelating AgentsIBA 04/2020
1	Doxycycline (Periostat)FDA LinkGeneric 04/2020
1	CopperIBA 01/2020
1	Sulfides (Thioethers)IBA 01/2020
1	Toll-Like Receptor 9IBA 01/2020
1	isoquinolineIBA 01/2019
1	AlkaloidsIBA 01/2019
1	Particulate MatterIBA 01/2019
1	ResveratrolIBA 01/2019
1	Sirtuin 1IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	norisoboldineIBA 01/2019
1	Growth Factor ReceptorsIBA 05/2018
1	Aluminum Oxide (Sapphire)IBA 05/2018
1	Annexin A1IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	VimentinIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Axl Receptor Tyrosine KinaseIBA 01/2017
1	AntigensIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	tanespimycin (17AAG)IBA 01/2017
1	fosbretabulin (combretastatin A4)IBA 11/2016
1	Ethiodized Oil (Ethiodol)FDA Link 11/2016
1	Phosphates (Orthophosphate)IBA 11/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2016
1	MicellesIBA 03/2015
1	Lutetium-177IBA 03/2015
1	APTIBA 05/2014
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 04/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2014
1	Oncogene Proteins (Oncogene Protein)IBA 04/2014
1	CateninsIBA 04/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	Single-Chain AntibodiesIBA 01/2012
1	Immunotoxins (Immunotoxin)IBA 01/2012

Therapy/Procedure

8	Therapeutics 12/2021 - 11/2003
5	Lasers (Laser) 01/2020 - 07/2015
5	Drug Therapy (Chemotherapy) 01/2020 - 01/2004
4	Nanospheres 01/2020 - 05/2014
4	Radiotherapy 01/2018 - 07/2007
2	Aftercare (After-Treatment) 03/2015 - 01/2004
1	Thyroidectomy 12/2021
1	Immunotherapy 01/2019
1	Photothermal Therapy 07/2015